Precursor Cell Lymphoblastic Leukemia-Lymphoma
Showing 9951 - 9975 of >10,000
BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)
Active, not recruiting
- BRCA1 Gene Mutation
- +5 more
- Durvalumab
- +3 more
-
Buffalo, New York
- +1 more
Jan 20, 2023
Hepatocellular Carcinoma, Circulating Tumor Cell, Whole Genome Sequencing Trial in Chongqing
Recruiting
- Hepatocellular Carcinoma
- +2 more
-
Chongqing, Chinathe second affiliated hospital of Chongqing Medical University
Feb 7, 2022
Obesity, Type2diabetes, NAFLD Trial in Rochester (Glucagon response study)
Not yet recruiting
- Obesity
- +2 more
- Glucagon response study
-
Rochester, MinnesotaMayo Clinic in Rochester
Aug 11, 2022
Sickle Cell Disease, Hb-SS Disease, Hemoglobin S Trial run by the National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting
- Sickle Cell Disease
- +5 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 21, 2023
SARS-CoV2 Infection Trial in Mile (SARS-CoV-2 Vaccine, Inactivated (Vero Cell))
Recruiting
- SARS-CoV2 Infection
- SARS-CoV-2 Vaccine, Inactivated (Vero Cell)
-
Mile, Yunnan, ChinaMile City Centers for Disease Control and Prevention
Feb 14, 2022
Malignant Melanoma Trial in Herlev (Cyclophosphamide, Fludarabine Phosphate, Multiple Antigen Specific Endogenously derived T
Recruiting
- Malignant Melanoma
- Cyclophosphamide
- +3 more
-
Herlev, DenmarkNational Center for Cancer Immune Therapy (CCIT-DK)
Sep 14, 2021
Prognostic Value of Protein IMP3 Expression in Cervical Cancer
Active, not recruiting
- Cervical Carcinoma
- immunohistochemical analysis with murine monoclonal antihuman antibodies IMP3
- (no location specified)
Jan 5, 2022
Carcinoma,Non-Small-Cell Lung, Lung Carcinomas, Non-Small-Cell, Non-small-cell Lung Carcinoma Trial in Worldwide (Pemetrexed,
Active, not recruiting
- Carcinoma，Non-Small-Cell Lung
- +3 more
- Pemetrexed
- +5 more
-
Albury, New South Wales, Australia
- +192 more
Sep 19, 2022
Acute Myeloid Leukemia, Myelodysplasia Trial in United Kingdom (Oral azacitidine, Matched )
Recruiting
- Acute Myeloid Leukemia
- Myelodysplasia
- Oral azacitidine
- Matched placebo
-
Birmingham, United Kingdom
- +20 more
Oct 14, 2021
Triple Negative Breast Cancer Trial in Los Angeles (biological, procedure, drug)
Not yet recruiting
- Triple Negative Breast Cancer
- Aldesleukin
- +12 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 9, 2023
CIBMTR Research Database
Recruiting
- Autologous Stem Cell Transplantation
- +6 more
-
Minneapolis, Minnesota
- +1 more
Jan 20, 2023
Cell-free DNA From Junction of Hepatitis B Virus Integration in
Active, not recruiting
- Hepatocellular Carcinoma
-
Taipei, TaiwanNational Taiwan University Hospital
Apr 10, 2023
Cancer of Unknown Primary Site, Unknown Primary Cancer, Unknown Primary, Squamous Cell Carcinoma Trial in Copenhagen, Århus
Recruiting
- Cancer of Unknown Primary Site
- +2 more
- Transoral Ultrasound
-
Copenhagen, Denmark
- +1 more
May 2, 2023
Autoimmune Cytopenias Including Autoimmune Hemolytic Anemia,
Recruiting
- Autoimmune Hemolytic Anemia
- +5 more
- cytokine essays
- +6 more
-
Milano, ItalyFondazione Irccs Ca' Granda Ospedale Maggiore Policlinico
Jul 3, 2023
Neuroblastoma, High-Risk Trial in New York (cyclophosphamide, NK cells, hu3F8)
Active, not recruiting
- Neuroblastoma
- High-Risk
- cyclophosphamide
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 14, 2022
Endometrial Endometrioid Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in
Completed
- Endometrial Endometrioid Adenocarcinoma
- +5 more
- Copanlisib
- Laboratory Biomarker Analysis
-
New Haven, Connecticut
- +42 more
Jan 25, 2022
Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +2 more
- Panitumumab
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Feb 16, 2023
Gastric Cancer Stage IV Trial in Seoul (olaparib+pembrolizumab+paclitaxel)
Not yet recruiting
- Gastric Cancer Stage IV
-
Seoul, Korea, Republic ofSeverance Hospital
Aug 29, 2021
Renal Cell Carcinoma, Clear Cell Renal Cell Carcinoma Trial in Tianjin (Sintilimab, Axitinib)
Not yet recruiting
- Renal Cell Carcinoma
- Clear Cell Renal Cell Carcinoma
-
Tianjin, Tianjin, ChinaTianjin Medical Unversity Second Hospital
Jul 1, 2021
Leukemia, Myeloid, Acute Trial in United States (PNK-007, Cyclophosphamide, Fludarabine)
Terminated
- Leukemia, Myeloid, Acute
- PNK-007
- +3 more
-
Boston, Massachusetts
- +6 more
Jul 20, 2020
Diffuse Large B-cell Lymphoma, Follicle Center Lymphoma Trial in Worldwide (Zevalin, Y-90-Zevalin, Rituximab)
Terminated
- Diffuse Large B-cell Lymphoma
- Follicle Center Lymphoma
- Zevalin
- +3 more
-
Casa Grande, Arizona
- +92 more
Nov 18, 2021
Head and Neck Squamous Cell Carcinoma, Oral Mucositis Trial in Korea, Republic of, United States (MIT-001 plus CCRT)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Oral Mucositis
- MIT-001 plus CCRT
-
Gilbert, Arizona
- +14 more
Jan 27, 2022
Smoking Cessation, HIV Trial in Boston, Guangxi (Sessions with a trained counselor, Cell phone messages, Offered nicotine
Enrolling by invitation
- Smoking Cessation
- HIV Infections
- Sessions with a trained counselor
- +3 more
-
Boston, Massachusetts
- +1 more
Mar 3, 2022
Squamous Cell Cancer
Recruiting
- Squamous Carcinoma
- +5 more
-
Umeå, SwedenUmeå University
Sep 28, 2021
Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)
Recruiting
- Crohn's Disease
- autologous CD34-selected peripheral blood stem cells transplant
- +8 more
-
Pittsburgh, Pennsylvania
- +1 more
Feb 9, 2022